Sr One Capital Management
Latest statistics and disclosures from Sr One Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACLX, DSGN, Mineralys Therapeutics, SPRY, NKTX, and represent 99.11% of Sr One Capital Management's stock portfolio.
- Added to shares of these 2 stocks: Mineralys Therapeutics (+$28M), SPRY (+$6.5M).
- Started 1 new stock positions in Mineralys Therapeutics.
- Sr One Capital Management was a net buyer of stock by $35M.
- Sr One Capital Management has $269M in assets under management (AUM), dropping by -2.00%.
- Central Index Key (CIK): 0001910264
Tip: Access up to 7 years of quarterly data
Positions held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 6 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 63.1 | $170M | 5.5M | 30.81 |
|
|
| Design Therapeutics (DSGN) | 14.0 | $38M | 6.5M | 5.77 |
|
|
| Mineralys Therapeutics | 10.5 | $28M | NEW | 1.8M | 15.66 |
|
| Silverback Therapeutics (SPRY) | 9.7 | $26M | +33% | 4.0M | 6.51 |
|
| Nkarta (NKTX) | 1.8 | $4.7M | 1.3M | 3.55 |
|
|
| Effector Therapeutics (EFTR) | 0.9 | $2.4M | 6.8M | 0.35 |
|
Past Filings by Sr One Capital Management
SEC 13F filings are viewable for Sr One Capital Management going back to 2021
- Sr One Capital Management 2023 Q1 restated filed May 19, 2023
- Sr One Capital Management 2023 Q1 filed May 9, 2023
- Sr One Capital Management 2022 Q4 filed Feb. 8, 2023
- Sr One Capital Management 2022 Q3 filed Nov. 8, 2022
- Sr One Capital Management 2022 Q2 filed Aug. 2, 2022
- Sr One Capital Management 2022 Q1 filed May 10, 2022
- Sr One Capital Management 2021 Q4 filed Feb. 14, 2022